A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.
Antimicrob Agents Chemother
; 67(1): e0045222, 2023 01 24.
Article
in En
| MEDLINE
| ID: mdl-36515544
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2023
Document type:
Article
Affiliation country:
Corea del Sur
Country of publication:
Estados Unidos